Leveraging a Clinical Phase Ib Proof-of-Concept Study for...

  • Main
  • 2017 / 07
  • Leveraging a Clinical Phase Ib Proof-of-Concept Study for...

Leveraging a Clinical Phase Ib Proof-of-Concept Study for the GPR40 Agonist MK-8666 in Patients With Type 2 Diabetes for Model-Informed Phase II Dose Selection

Krug, AW, Vaddady, P, Railkar, RA, Musser, BJ, Cote, J, Ederveen, AGH, Krefetz, DG, DeNoia, E, Free, AL, Morrow, L, Chakravarthy, MV, Kauh, E, Tatosian, DA, Kothare, PA
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical and Translational Science
DOI:
10.1111/cts.12479
Date:
July, 2017
File:
PDF, 679 KB
english, 2017
Conversion to is in progress
Conversion to is failed